Itm Isotopen Technologien München Ag

passion for precision. itm isotopen technologien münchen ag is a privately held group of companies dedicated to the development, production and global supply of innovative diagnostic and therapeutic radionuclides and radiopharmaceuticals. since its foundation in 2004, itm and its subsidiaries have established gmp manufacturing and a robust global supply network of a novel, first-in-class radionuclides and -generator platform for a new generation of targeted cancer diagnostics and therapies. furthermore, itm is developing a proprietary portfolio of targeted treatments in various stages of clinical development addressing a range of cancers such as neuroendocrine cancers or bone metastases. itm’s main objectives, together with its collaboration partners worldwide, are to significantly improve outcomes and quality of life for cancer patients while at the same time reducing side-effects and improving health economics through a new generation of targeted radionuclide therapies in precision o